Alnylam Pharmaceuticals, Inc. (LON:0HD2)

Alnylam Pharmaceuticals Statistics

Total Valuation

LON:0HD2 has a market cap or net worth of GBP 44.20 billion. The enterprise value is 44.11 billion.

Market Cap	44.20B
Enterprise Value	44.11B

Important Dates

The last earnings date was Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	131.08M
Shares Outstanding	n/a
Shares Change (YoY)	+2.84%
Shares Change (QoQ)	+0.73%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	126.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	74.62
PS Ratio	24.59
PB Ratio	241.63
P/TBV Ratio	241.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-189.38
EV / Sales	24.13
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1,160.15

Financial Position

The company has a current ratio of 2.80, with a Debt / Equity ratio of 10.93.

Current Ratio	2.80
Quick Ratio	2.63
Debt / Equity	10.93
Debt / EBITDA	n/a
Debt / FCF	-52.60
Interest Coverage	-1.18

Financial Efficiency

Return on equity (ROE) is -257.82% and return on invested capital (ROIC) is -3.95%.

Return on Equity (ROE)	-257.82%
Return on Assets (ROA)	-2.63%
Return on Invested Capital (ROIC)	-3.95%
Return on Capital Employed (ROCE)	-5.52%
Revenue Per Employee	805,824
Profits Per Employee	-104,441
Employee Count	2,230
Asset Turnover	0.57
Inventory Turnover	5.17

Taxes

Income Tax	-44.15M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +66.27% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+66.27%
50-Day Moving Average	370.49
200-Day Moving Average	287.88
Relative Strength Index (RSI)	70.94
Average Volume (20 Days)	1,458

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.18

Income Statement

In the last 12 months, LON:0HD2 had revenue of GBP 1.80 billion and -232.90 million in losses. Loss per share was -1.80.

Revenue	1.80B
Gross Profit	1.50B
Operating Income	-131.52M
Pretax Income	-277.05M
Net Income	-232.90M
EBITDA	-90.28M
EBIT	-131.52M
Loss Per Share	-1.80

Balance Sheet

The company has 2.09 billion in cash and 2.00 billion in debt, giving a net cash position of 86.02 million.

Cash & Cash Equivalents	2.09B
Total Debt	2.00B
Net Cash	86.02M
Net Cash Per Share	n/a
Equity (Book Value)	182.91M
Book Value Per Share	1.40
Working Capital	1.71B

Cash Flow

In the last 12 months, operating cash flow was -11.34 million and capital expenditures -26.68 million, giving a free cash flow of -38.02 million.

Operating Cash Flow	-11.34M
Capital Expenditures	-26.68M
Free Cash Flow	-38.02M
FCF Per Share	n/a

Margins

Gross margin is 83.64%, with operating and profit margins of -7.32% and -12.96%.

Gross Margin	83.64%
Operating Margin	-7.32%
Pretax Margin	-15.42%
Profit Margin	-12.96%
EBITDA Margin	-5.02%
EBIT Margin	-7.32%
FCF Margin	n/a

Dividends & Yields

LON:0HD2 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.84%
Shareholder Yield	n/a
Earnings Yield	-0.53%
FCF Yield	-0.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0HD2 has an Altman Z-Score of 3.49 and a Piotroski F-Score of 1.

Altman Z-Score	3.49
Piotroski F-Score	1